In 2016, a randomized trial from NYU found that a single dose of psilocybin delivered rapid improvements in anxiety and depression in cancer patients when combined with psychotherapy. A follow-up study found that 71–100% of participants reported that the improvement in depression and anxiety had lasted five years—with participants “rating it among the most personally meaningful experiences of their lives.”

ACCESS STUDY

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.